Second Opinions in Oncology

NCT05102500 | Completed DMC

• 1 other identifier: 21-3100.cc
• Study Type: observational
• Target: 236
• Locations: 1 country
• Sites: 1

Brief Summary

The long-time goal is to understand what decision-making process and patient characteristics factor into a patient deciding to stay with their initial physician versus seeking treatment with a second opinion.

Conditions

Colorectal Cancer; Breast Cancer; Pancreatic Cancer

Outcome Measures

Primary Outcomes (1)

• Second opinion retention rates for cancer patients at University of Colorado

  a. The study team will perform a retrospective chart review to identify patients with breast cancer, colorectal cancer or pancreatic cancer who were seen by a surgeon at the University of Colorado for a second opinion and to examine whether or not the subject stayed at the Cancer Center to receive cancer care. The study team predict the second opinion retention rate - the percent of patients who received a second opinion at the Cancer Center and ultimately received care at this institution - will be significantly higher for pancreatic cancer patients than for breast and colorectal cancer patients.

  12 months

Secondary Outcomes (1)

• Univariate statistical analysis affecting second opinion retention rates

  12 months

Other Outcomes (1)

• Patient opinions on decision making process through semi-structure interviews

  12 months

Study Arms (2)

Retrospective Chart Review Patients

The PI will conduct a retrospective chart review of breast cancer, colorectal cancer, and pancreatic cancer patients to better understand the patient, disease, and treatment characteristics that play a role in second opinion retention rates.

Semi-structure Interview Patients

The PI will conduct semi-structured interviews with breast cancer, colorectal cancer and pancreatic cancer patients to better understand the decision-making process that goes into continued care with their primary or second opinion physician.

Eligibility Criteria

• Age: 18 Years - 100 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Cancer patients who are 18 years of age or older who received a second opinion at the University of Colorado will be included in the retrospective chart review and analysis. A subset of these patients will be invited to participate in semi-structured interviews

You may qualify if:

• Cancer patients who are 18 years of age or older who received a second opinion at the University of Colorado.
• A subset of these patients will be invited to participate in semi-structured interviews

You may not qualify if:

• Patients under the age of 18.
• Patients who did not receive a second opinion at the University of Colorado.

Sponsors & Collaborators

• University of Colorado, Denver: lead

Study Sites (1)

University of Colorado Hospital

Aurora, Colorado, 80045, United States

Location

MeSH Terms

Conditions

Breast Neoplasms; Pancreatic Neoplasms; Colorectal Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Breast Diseases; Skin Diseases; Skin and Connective Tissue Diseases; Digestive System Neoplasms; Endocrine Gland Neoplasms; Digestive System Diseases; Pancreatic Diseases; Endocrine System Diseases; Intestinal Neoplasms; Gastrointestinal Neoplasms; Gastrointestinal Diseases; Colonic Diseases; Intestinal Diseases; Rectal Diseases

Study Officials

• Sarah Tevis

  Colorado Research Center

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: October 19, 2021
• First Posted: November 1, 2021
• Study Start: May 14, 2021
• Primary Completion: December 2, 2021
• Study Completion: May 10, 2024
• Last Updated: February 3, 2026

Record last verified: 2026-02

Locations

US (1)